Barclays 23rd Annual Global Technology Conference December 10, 2025 2:00 PM ESTCompany ParticipantsAshim Gupta - CFO & ...

UiPath is deepening its role inside enterprise workflows, and institutional capital is noticing. This breakdown highlights ...

UiPath presents a compelling accumulation opportunity after recent profit-taking, with core RPA business strength and visible AI-driven growth catalysts. PATH's revenue growth has stabilized at double ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

In a nutshell, UBI is a small Rust program that installs binaries from GitHub or GitLab. Software developers don't just ...

UiPath Inc. (NYSE: PATH) stock jumped in Wednesday's extended trading after the company released its third quarter earnings ...

Shares of UiPath rose after the company swung to a third-quarter profit on higher sales, helped by growing demand for its artificial intelligence offerings. The stock rose 4.5% to $15.53 in ...

UiPath’s stock rose more than 7% in extended trading on the strong results and its solid guidance. For the current quarter, ...

UiPath Inc (NYSE: PATH) stocks surged after reporting strong Q3 results, with Canaccord Genuity analyst raising price target to $19 and Needham maintaining Hold rating.

Medicine can get into your body in a few different ways. You can swallow a pill, drink a liquid, or get a shot. A suppository is another way to deliver a drug. It's a small, round or cone-shaped ...

What Happened? Shares of automation software company UiPath (NYSE:PATH) jumped 24.2% in the afternoon session after the ...